Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep145 | Clinical case reports - Thyroid/Others | ECE2017

Insulinoma masquerading as neurologic disease

Machado Catarina , Tavares Patricia , Monteiro Sara , Rocha Gustavo , Oliveira Maria Joao

Introduction: Insulinomas are the most frequent cause of hypoglycemia and the most common functional endocrine pancreatic tumors. Whipple triad is often present and should alert to the diagnosis.Case report: A 36-year-old male was admitted in the emergency room with loss of consciousness, diaphoresis and blurred vision, and hypoglycemia (50 mg/dl). The patient recalled recurrent symptoms of diaphoresis, tremors and palpitations, sometimes with loss of co...

ea0049ep1211 | Clinical case reports - Thyroid/Others | ECE2017

Thyroid storm subsequent to amiodarone-induced thyrotoxicosis

Machado Catarina , Tavares Patricia , Monteiro Sara , Rocha Gustavo , Oliveira Maria Joao

Introduction: Thyroid storm is a rare medical emergency with high mortality, which usually results from acute exacerbation of hyperthyroidism. Amiodarone is a highly used class III antiarrhythmic drug and amiodarone-induced thyrotoxicosis is an infrequent effect of this medication, whose treatment may be difficult.Case study: A 20-year old male with congenital cardiomyopathy (Fallot tetralogy and Ebstein anomaly), chronically medicated with amiodarone 20...

ea0049ep1351 | Thyroid (non-cancer) | ECE2017

Outcome of radioiodine therapy in patients with hyperthyroidism

Machado Catarina , Tavares Patricia , Monteiro Sara , Rocha Gustavo , Silva Fernando , Oliveira Jose Manuel , Oliveira Maria Joao

Introduction: Radioiodine treatment (RAIT) is an effective definitive treatment for GravesÂ’ Disease (GD) and Toxic Nodular Goiter (TNG). The aim of this study was to analyze demographic and clinical factors affecting the outcome of RAIT in patients with hyperthyroidism.Methods: Retrospective review of patients treated with RAIT for hyperthyroidism. A fixed dose of 10 mCi was administered to patients with GD and 15 mCi to patients with TNG. Treatment...

ea0032p537 | Endocrine tumours and neoplasia | ECE2013

RPS13 and cell cycle signaling pathways in pituitary tumorigenesis

Martins Clarissa , Camargo Renata , Saggioro Fabiano , Neder Luciano , Machado Helio , Moreira Ayrton , Castro Margaret

Introduction: Abnormalities in cell cycle pathways, such as CDKN1B (p27) underexpression, have been identified in the pathogenesis of pituitary adenomas, but their underlying mechanisms have not been elucidated. Ribosomal proteins have been recently related to pituitary tumorigenesis. In gastric cancer, RPS13 down-regulates p27 and promotes cell cycle progression; these mechanisms have not yet been explored in pituitary adenomas.Objective: To evaluate th...

ea0029p789 | Endocrine tumours and neoplasia | ICEECE2012

The pathogenesis of non functioning pituitary adenoma with positive staining for glycoproteins is associated with MEG3/DLK1 underexpression/GSTP1 overexpression and modulated by microRNAs (miRNAs)

Paixao B. , Lima D. , Peitl P. , Dinarte A. , Saggioro F. , Moreira A. , Silva W. , Machado H. , Castro M.

Context: Pathogenesis underlying non functioning pituitary adenoma (NFPA) formation and progression has not been well established. MEG3 is strongly expressed in the normal pituitary (NP) but not in NFPA derived from gonadotroph cells. High GSTP1 gene expression also seems to contribute to gonadotroph adenoma development. Recent reports indicate a role of miRNAs in the pituitary adenoma pathogenesis.Objective: To evaluate the expression of MEG3, DLK1, GST...

ea0029p1213 | Obesity | ICEECE2012

SUR2a gene is upregulated in skeletal muscle insulin resistance of obese rats: correlation with GLUT4 gene

Felipe dos Santos Ferreira Marques M. , Cristina Tieko Mori R. , Mitiko Okamoto M. , Fabres Machado U.

Objective: The aim of this study was to investigate whether SUR2A (sulfonylurea receptor type 2A, ABCC9) MEF2a (myocyte enhancer factor-2a) and HIF1a (Hypoxia-inducible factor-1) can influence glucose uptake in oxidative muscle soleus by regulating GLUT4 expression.Methods: Insulin resistance was induced in male Wistar rats by inducing obesity with monosodium glutamate (MSG). At the age 3 months, half control and MSG-treated animals started receiving 0.1...

ea0026p346 | Obesity | ECE2011

AM251, a CB1 receptor antagonist, increases GLUT4 expression in adipocytes

Furuya D T , Poletto A C , Freitas H S , Machado U F

Evidences have suggested that the endocannabinoid system is overactive in obesity, resulting in enhanced endocannabinoid levels in both circulation and visceral adipose tissue. The cannabinoid CB1 receptor is expressed in the adipose tissue besides the brain. Few studies in vitro suggest that CB1 activation increases glucose uptake in adipocytes. The objective of the present study was to investigate the CB1 receptor modulation on glucose transporter GLUT4 expression, which is ...

ea0026p358 | Steroid metabolism | ECE2011

Chronic effect of 17β estradiol on GLUT4 expression in 3T3-L1 adipocytes

Campello R S , Poletto A C , Furuya D T , Mori R C T , Machado U F

Introduction: Insulin resistance results from a combination of genetic and environmental factors and it may be considered the primary cause of the development of metabolic disorders, such as type 2 diabetes mellitus. It is characterized by a reduced ability of insulin sensitivity tissues to respond to normal levels of the hormone. In these tissues, glucose transport stimulated by insulin occurs through the glucose transporter 4 and alterations in its expression are related to ...

ea0022p271 | Diabetes | ECE2010

ESE Young Investigator Award

dos Santos Ferreira Marques Milano Felipe , Mori Rosana Cristina Tieko , Okamoto Maristela Mitiko , Machado Ubiratan Fabres

Introduction: GLUT4 protein is the most important isoform of glucose transporters in skeletal muscle. Reduction in its content and/or translocation is related to insulin resistance and type 2 diabetes mellitus. In skeletal muscle cells there is also an ATP-sensitive potassium (KATP) channel with two subunits, sulfonylurea receptor type 2A, ABCC9 (SUR2A) and KIR6.2 (KCNJ11). In pancreatic B cells, this channel triggers insulin secretion in response to the rise in glucose levels...

ea0022p566 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Euthyroidism and tumor stability achieved in a TSH-secreting pituitary macroadenoma treated with octreotide-LAR and cabergoline: case report and literature review

Simoes Helder , Lalanda Carolina , Oliveira Manuela , Raposo Luis , Duarte Sequeira , Saraiva Machado

Introduction: TSH-secreting adenomas represent <2% of pituitary tumors. Surgery and/or radiotherapy are primary treatment options. Somatostatin analogues and also dopamine agonists, represent valuable alternatives or adjuvant therapies.Objective: To report a case of euthyroidism and tumor stability achieved in a TSH-secreting pituitary macroadenoma, treated with octreotide-LAR, as first line therapy, and then added cabergoline. To review the efficacy...